Teresa Bitetti
Insider · Takeda Pharmaceutical Co. Ltd (TAK)
planned sales: $940,104
| Date | Trade | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|
| November 1, 2026 | Planned sale | 46,609 | — | $940,104 | SEC |
Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.
